@article{c369ff097b164ee0bf058ed9dcf94b6d,
title = "Overview of laboratory methods to monitor innovative treatment regimens in multiple sclerosis",
keywords = "PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY, NEUTRALIZING ANTIBODIES, INTERFERON-BETA, NEUROMYELITIS-OPTICA, NATURAL-HISTORY, ORAL FINGOLIMOD, NATALIZUMAB, PATHOGENESIS, PREDICTORS, DISABILITY",
author = "J{\"o}rg Kraus and Georg Pilz and Peter Wipfler and Barbara Holl and Katrin Oppermann and Stefan Golaszewski and Andrea Harrer",
note = "alle: Universit{\"a}tsklinik f{\"u}r Neurologie, Paracelsus Medizinische Privatuniversit{\"a}t, Christian-Doppler-Klinik/Salzburger Landeskliniken, Salzburg, {\"O}sterreich",
year = "2012",
doi = "10.1515/labmed-2012-0018",
language = "Deutsch",
volume = "36",
pages = "389--396",
journal = "LaboratoriumsMedizin-Journal of Laboratory Medicine",
issn = "0342-3026",
number = "6",
}